Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Disease, Chronic Obstructive

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease

NCT02233894

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease

NCT02233907

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease

NCT02233881

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

NCT02232594

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

NCT02231359

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

NCT02231320

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease

NCT02231346

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

NCT01694771

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: 1222.51.01055 Boehringer Ingelheim Investigational Site Florence, Alabama, United States

1222.51.01087 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States

1222.51.01066 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States

1222.51.01069 Boehringer Ingelheim Investigational Site Scottsdale, Arizona, United States

View all 90 locations

View Trial Details

Completed

Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease

NCT02231437

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease

NCT02231424

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details